510(k) Report

510(k) · Cleared

Cleared

Panosol II Tru-Blu, Model Ubl-417

K070934510(k) TraditionalCleared May 22, 200749-day reviewClass II21 CFR 878.4630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

National Biological Corp. · FTC Light, Ultraviolet, Dermatological

Cleared on May 22, 2007 after a 49-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 7 later devices descend from it.

Decided
May 22, 2007
Review
49 days
Class
Class II
Product code
FTC
Recalls
None
Predicates
0

7 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2011: 1 descendant cleared2018: 1 descendant cleared2021: 2 descendants cleared2023: 1 descendant cleared2026: 1 descendant cleared20052010201520202025
  1. This deviceK070934 Panosol II Tru-Blu, Model Ubl-417National Biological Corp. · 2007
  2. Descendant · cites it directly · 6 of its ownK100378 1 Series Model 1 Series T2, 1 Series X2, 1 Series T4, 1 Series X4Daavlin Distributing Co. · 2010 · Recalled
  3. Descendant · 2 generations on · 4 of its ownK182215 ClearLink Controlled Phototherapy EquipmentDaavlin Distributing Company · 2018 · Recalled
  4. Descendant · 2 generations on · 2 of its ownK210881 M Series Phototherapy EquipmentDaavlin Distributing Co. · 2021 · Recalled
  5. Descendant · 3 generations on · 1 of its ownK230382 3 Series NeoLuxDaavlin Distributing Co. · 2023
  6. Descendant · 4 generations on · 0 of its ownK261775 Uv Phototherapy (KN-4001A,KN-4001B,KN-4001AB)Xuzhou Kernel Medical Equipment Co., Ltd. · 2026

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2010: 12011: 12018: 12021: 22023: 12026: 1
2010high 2 (2021) · low 0 (2012)2026

Most influential descendants

Showing 5 of 7 · See all
  • K1003781 Series Model 1 Series T2, 1 Series X2, 1 Series T4, 1 Series X4Daavlin Distributing Co. · 2010 · cites it directly6descendants
  • K182215ClearLink Controlled Phototherapy EquipmentDaavlin Distributing Company · 2018 · 2 generations on4descendants
  • K210881M Series Phototherapy EquipmentDaavlin Distributing Co. · 2021 · 2 generations on2descendants
  • K2303823 Series NeoLuxDaavlin Distributing Co. · 2023 · 3 generations on1descendant
  • K261775Uv Phototherapy (KN-4001A,KN-4001B,KN-4001AB)Xuzhou Kernel Medical Equipment Co., Ltd. · 2026 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K070934Panosol II Tru-Blu, Model Ubl-417National Biological Corp.2007—
+1K1003781 Series Model 1 Series T2, 1 Series X2, 1 Series T4, 1 Series X4Daavlin Distributing Co.20101
+2K182215ClearLink Controlled Phototherapy EquipmentDaavlin Distributing Company20181
+2K210881M Series Phototherapy EquipmentDaavlin Distributing Co.20211
+3K2303823 Series NeoLuxDaavlin Distributing Co.2023—
+4K261775Uv Phototherapy (KN-4001A,KN-4001B,KN-4001AB)Xuzhou Kernel Medical Equipment Co., Ltd.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201110
201810
202120
202310
202610
FIG. 1 — Lineage of K070934, 2007–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FTC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FTC device

  1. #1 K242977 308nm Excimer Phototherapy Device (CN-308E…score 14.8 · 21 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (7)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K1003781 Series Model 1 Series T2, 1 Series X2, 1 Series T4, 1 Series X4Daavlin Distributing Co.20106

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K100378 (Daavlin Distributing Co., 2010) has gone furthest, with 6 descendants of its own.

How does its category compare?

All FTC devices

FTC Light, Ultraviolet, Dermatological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · FTC

3in 2025

2007: 42008: 32009: 22010: 12011: 52012: 12013: 12014: 22015: 32016: 12017: 22018: 32019: 22020: 52021: 32022: 12023: 42024: 12025: 32026 (partial year): 4
2007high 5 (2011) · low 1 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FTC

76in 2025

2007: 53 days median2008: 41 days median2011: 125 days median2015: 98 days median2018: 88 days median2020: 237 days median2021: 89 days median2023: 48 days median2025: 76 days median2026 (partial year): 91 days median
2007high 237 (2020) · low 41 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FTC

3so far in 2026, the most since 2007

2008: 12025: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FTC

8in 2025

2010: 22012: 12013: 12014: 12015: 82016: 22017: 22019: 142020: 42021: 482022: 42023: 52024: 42025: 8
2007high 48 (2021) · low 0 (2007)2025

MAUDE reports naming product code FTC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200745300
200834110
20092—00
20101—02
2011512500
20121—01
20131—01
20142—01
201539808
20161—02
20172—02
201838800
20192—014
2020523704
2021389048
20221—04
202344805
20241—04
202537618
20264913—

What is it indicated for?

The Panosol II Tru-Blu UBL-417 is generally indicated to treat dermatological

indications. The Panosol II Tru-Blu UBL-417 is specifically indicated to treat

moderate inflammatory Acne Vulgaris

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K070934: Panosol II Tru-Blu, Model Ubl-417.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K070934

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026